Ticker: JPM

JPMorgan Chase

Finance Financials Banks - Diversified
Price 356.20
Reco Buy Potential 75 Risk 30 Updated 2026-07-27

Forecast impact

limited
Target +5.3% target fill 95.0%
Reaction D5 +3.41% · D10 pending fresh confirmed · market trust
Impact Potential 0 · Risk 0 valid until 2026-08-21

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

JPMorgan Chase is a leading global financial services firm offering a range of products and services, including investment banking, financial services for consumers and businesses, financial transaction processing, asset management, and private equity. Its major business segments include Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset & Wealth Management. The primary revenue sources are net interest income and non-interest income from fees and commissions.

Investment Profile

The stock presents a balanced investment profile, appealing to investors seeking a mix of growth and income through dividends. Its stable earnings and moderate dividend yield suggest it may suit those looking for steady returns rather than high growth. The company has demonstrated consistent revenue growth, indicating potential for value appreciation over time.

Fundamental metrics (experimental) Updated: 2026-07-27
EPS (TTM) — earnings per share for the last 12 months, $
23.26
Revenue QoQ — quarter-over-quarter revenue growth
11.9%
EPS surprise
35.8%
20d volatility
1.1%
Dividend yield
1.7%
last ex-date
2026-07-06
AI recommendation changes
Date Before After Reason
2026-06-05 Hold Buy Strong fundamentals and positive momentum signal growth potential.
2026-06-01 Buy Hold Stable earnings but negative short-term momentum concerns.
2026-05-24 Hold Buy Solid fundamentals, but mixed momentum signals present risks.
Analyst forecasts
Date Analyst Action Target Price Then
2026-07-22 Deutsche Bank Rating Upgraded — → 375 348.21
2026-07-15 Truist Financial Target Raised 344 → 352 347.88
2026-07-15 RBC Capital Target Raised 330 → 370 342.89
News Page 5 of 6
JPMorgan Chase GSK

JPMorgan Analysts Highlight Reopening Biotech IPO Market Amid Continued Big Pharma M&A Activity

The biotech sector is experiencing a resurgence in public market activity, but many leading companies may prefer acquisition by larger pharmaceutical firms over pursuing initial public offerings (IPOs). This trend reflects a selective investment climate and a strategic shift in how biotech firms approach growth and funding.
JPMorgan Chase Microsoft Barclays

Former Barclays CEO Jes Staley to be Interviewed by House Oversight Committee Regarding Relationship with Jeffrey Epstein

Jes Staley, the former CEO of Barclays, will be interviewed by the House Oversight Committee regarding his ties to Jeffrey Epstein, which could have significant implications for JPMorgan and the broader financial sector given the ongoing scrutiny of Epstein's connections and the bank's settlements related to his activities.
JPMorgan Chase Goldman Sachs IBM Morgan Stanley Bank of America

IBM CEO Arvind Krishna Highlights Anthropic’s Mythos as Key Driver for $5 Billion Cybersecurity Investment

IBM's CEO Arvind Krishna highlighted the significance of Anthropic's Mythos in the company's $5 billion investment in a new cybersecurity initiative aimed at addressing vulnerabilities in open-source software, which has already attracted major U.S. banks as early adopters.